A complete blood count, or CBC, is the first blood test that can show signs of leukemia. It measures your red blood cells, white blood cells, and platelets, and abnormal levels of any of these can raise a red flag. But a CBC alone can’t confirm leukemia. Diagnosis typically requires a sequence of increasingly specific tests, starting with that initial blood draw and sometimes ending with genetic analysis of the abnormal cells themselves.
The Complete Blood Count (CBC)
The CBC is the standard starting point. It’s a routine blood test that counts the different types of cells circulating in your blood and flags when those numbers fall outside normal ranges. A normal white blood cell count runs between 4,500 and 11,000 cells per microliter of blood. In leukemia, the white blood cell count is often elevated well above that range, though in some forms it can actually be lower than normal.
What makes a CBC suggestive of leukemia isn’t just one abnormal number. It’s often a pattern: white blood cells that are too high or too low, red blood cells that are low (causing anemia), and platelets that are low (increasing bleeding and bruising risk). Leukemia crowds out normal blood cell production in the bone marrow, so the counts of healthy cells tend to drop even as abnormal white cells multiply. Your doctor may order a CBC because of symptoms like persistent fatigue, frequent infections, unexplained bruising, or unusual bleeding, or the abnormality might show up on routine bloodwork done for an unrelated reason.
The Peripheral Blood Smear
If the CBC comes back abnormal, the next step is usually a peripheral blood smear. For this test, a pathologist places a thin layer of your blood on a glass slide and examines it under a microscope. The goal is to look at the actual shape and maturity of your blood cells, not just count them.
The key finding here is the presence of blast cells. Blasts are immature blood cells that normally stay in the bone marrow while they develop. Mature, fully formed blood cells are the only ones that should be circulating in your bloodstream. When blasts show up in a blood smear, it signals that something has gone wrong with normal blood cell development. If they look abnormal under the microscope, leukemia becomes a strong possibility. Having 20% or more blasts in the blood or bone marrow is a diagnostic marker for several forms of leukemia. A blood smear can also reveal other clues, like unusually shaped red blood cells or a shortage of platelets, that support the diagnosis.
Flow Cytometry
Once abnormal cells are found, doctors need to know exactly what type they are. Flow cytometry is the test that answers this question. It works by passing individual blood cells through a laser beam one at a time and analyzing the proteins on each cell’s surface. Different types of blood cells carry different surface markers, almost like identification tags.
This test is essential for determining the lineage of the leukemia, meaning whether the cancer started in cells that were developing into one type of white blood cell versus another. That distinction matters enormously because it determines which specific type of leukemia you have and, by extension, which treatments are most effective. Flow cytometry can also pick up on subtle abnormalities in cells that look normal under a microscope, making it a more sensitive tool than visual examination alone.
Bone Marrow Biopsy
Blood tests can strongly suggest leukemia, but the bone marrow biopsy is what confirms it. A specialist uses a needle to withdraw a small sample of liquid marrow (aspiration) and a tiny core of bone tissue, usually from the back of the hip bone. The samples go to a pathologist who evaluates whether the marrow is producing enough healthy blood cells and how many abnormal cells are present.
The biopsy provides information that blood tests simply can’t. It shows the percentage of blast cells in the marrow, reveals how extensively leukemia has disrupted normal blood cell production, and provides tissue for additional specialized testing. It also helps determine the stage or progression of the disease. Doctors order it when blood tests are abnormal or don’t provide enough information to explain what’s happening.
Genetic and Molecular Tests
Some of the most important information for treatment planning comes from genetic tests run on the leukemia cells themselves. These tests look for specific chromosome changes and gene mutations that define certain subtypes and predict how the disease will behave.
One well-known example is the Philadelphia chromosome, an abnormal chromosome found in nearly all cases of chronic myeloid leukemia (CML). Three main techniques are used to find it. Cytogenetics examines chromosomes directly under a microscope. FISH (fluorescence in situ hybridization) uses fluorescent probes to detect specific genetic changes that cytogenetics might miss. PCR (polymerase chain reaction) identifies the exact genetic transcript produced by the abnormality, which becomes critical for monitoring how well treatment is working over time. These tests can be run on blood samples or bone marrow samples depending on the situation.
Specific Thresholds for Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia (CLL), the most common leukemia in adults, has a particularly clear-cut blood test criterion. Diagnosis requires a sustained count of at least 5,000 B lymphocytes (a specific type of white blood cell) per microliter of blood, maintained for at least three months. This threshold, established by international guidelines published in the journal Blood, means CLL can often be diagnosed from blood tests alone without requiring a bone marrow biopsy, unlike most other forms of leukemia.
What Else Can Cause Abnormal Results
An abnormal CBC does not automatically mean leukemia. Many common, non-cancerous conditions can raise your white blood cell count. Bacterial and viral infections are the most frequent cause. Autoimmune and inflammatory diseases like rheumatoid arthritis can do it. So can allergic reactions, burn injuries, recent surgery, smoking, physical stress, certain medications, and even pregnancy. These conditions can push your white blood cell count above the normal range without any cancer being present.
This is exactly why the diagnostic process involves multiple layers of testing. An elevated white count gets your doctor’s attention. The blood smear shows whether immature or abnormal cells are present. Flow cytometry identifies what those cells are. And the bone marrow biopsy plus genetic testing pins down the specific diagnosis. Each step narrows the possibilities.
How Long Results Take
The timeline varies dramatically depending on which test you’re waiting on. A CBC result often comes back the same day or within 24 hours. A blood smear may take a day or two. But the more specialized tests, including flow cytometry, genetic analysis, and bone marrow biopsy results, can take a few weeks to process. That waiting period can feel agonizing, but these tests require careful, specialized analysis that can’t be rushed without compromising accuracy.